down arrow

Dermapharm Holding SE

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A2GS5D8
  • ETR: DMP
EUR
37.50
-0.95 (-2.47%)

Oct 02

ETR

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
285.15
305.80
295.53
294.90
272.15
302.40
290.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
285.15
305.80
295.53
294.90
272.15
302.40
290.67
Raw Material Cost
190.02
197.24
196.38
187.43
183.80
198.58
195.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
79.38
78.76
73.45
67.31
75.43
75.38
71.39
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.29
10.68
11.92
14.68
13.18
12.88
16.51
Selling and Distribution Expenses
49.90
47.74
50.82
45.07
47.62
48.08
60.23
Other Expenses
-9.17
-8.94
-8.54
-8.20
-8.86
-8.83
-8.79
Total Expenditure (Excl Depreciation)
239.92
244.98
247.20
232.50
231.42
246.66
255.26
Operating Profit (PBDIT) excl Other Income
45.199999999999996
60.8
48.3
62.400000000000006
40.7
55.7
35.4
Other Income
2.01
1.42
2.46
4.98
1.33
2.39
2.35
Operating Profit (PBDIT)
96.18
92.48
87.38
92.68
67.77
83.36
72.06
Interest
12.29
10.68
11.92
14.68
13.18
12.88
16.51
Exceptional Items
-30.00
0.00
-2.20
-1.80
-1.60
-1.20
4.30
Gross Profit (PBDT)
95.14
108.56
99.16
107.48
88.34
103.82
95.63
Depreciation
23.12
20.39
31.17
21.05
20.36
19.99
26.16
Profit Before Tax
30.77
61.40
42.08
55.15
32.64
49.30
33.69
Tax
6.79
16.38
10.01
14.05
11.63
16.47
15.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
23.22
45.20
36.89
41.23
20.89
33.41
20.51
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
23.22
45.20
36.89
41.23
20.89
33.41
20.51
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.07
-0.08
-0.73
-0.12
-0.00
-0.21
-1.46
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
23.16
45.12
36.15
41.11
20.89
33.20
19.05
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
536.71
738.86
694.38
649.22
608.25
638.56
604.42
Earnings per share (EPS)
0.47
0.84
0.69
0.77
0.39
0.62
0.38
Diluted Earnings per share
0.47
0.84
0.69
0.77
0.39
0.62
0.38
Operating Profit Margin (Excl OI)
24.92%
23.11%
18.19%
22.6%
16.93%
20.17%
14.98%
Gross Profit Margin
18.9%
26.75%
24.79%
25.84%
19.47%
22.91%
20.59%
PAT Margin
8.14%
14.78%
12.48%
13.98%
7.68%
11.05%
7.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -6.74% vs 3.49% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -48.56% vs 24.59% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 3.40% vs 7.30% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 14.95% vs -10.08% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Dermapharm Holding SE With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
285.15
143.48
141.67
98.74%
Other Operating Income
0.00
0.00
0.00
Total Operating income
285.15
143.48
141.67
98.74%
Raw Material Cost
190.02
145.06
44.96
30.99%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
79.38
0.00
79.38
Power Cost
0
0
0.00
Manufacturing Expenses
12.29
2.97
9.32
313.80%
Selling and Distribution Expenses
49.90
39.29
10.61
27.00%
Other Expenses
-9.17
0.73
-9.90
-1,356.16%
Total Expenditure (Excl Depreciation)
239.92
194.61
45.31
23.28%
Operating Profit (PBDIT) excl Other Income
45.24
-51.13
96.37
188.48%
Other Income
2.01
3.30
-1.29
-39.09%
Operating Profit (PBDIT)
96.18
-23.39
119.57
511.20%
Interest
12.29
2.97
9.32
313.80%
Exceptional Items
-30.00
3.55
-33.55
-945.07%
Gross Profit (PBDT)
95.14
-1.58
96.72
6,121.52%
Depreciation
23.12
24.44
-1.32
-5.40%
Profit Before Tax
30.77
-47.25
78.02
165.12%
Tax
6.79
-1.47
8.26
561.90%
Provisions and contingencies
0
0
0.00
Profit After Tax
23.22
-46.65
69.87
149.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
23.22
-46.65
69.87
149.77%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.07
0.00
-0.07
Other related items
0.00
0.00
0.00
Consolidated Net Profit
23.16
-46.65
69.81
149.65%
Equity Capital
0
0
0.00
Face Value
1.00
1.00
0.00
Reserves
536.71
665.58
-128.87
-19.36%
Earnings per share (EPS)
0.47
-0.26
0.73
280.77%
Diluted Earnings per share
0.47
-0.26
0.73
280.77%
Operating Profit Margin (Excl OI)
24.92%
-35.63%
0.00
60.55%
Gross Profit Margin
18.90%
-15.90%
0.00
34.80%
PAT Margin
8.14%
-32.51%
0.00
40.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 28.52 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -6.74% vs 3.49% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 4.81% vs -2.75% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.32 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -48.56% vs 24.59% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 11.00% vs 24.40% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.42 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 3.40% vs 7.30% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 41.87% vs 3.59% in Jun 2025

Quarterly - Interest
Interest 1.23 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 14.95% vs -10.08% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -6.82% vs -14.84% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.92%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading